3,3',4,5,5'-pentahydroxy-trans-stilbene, a resveratrol derivative, induces apoptosis in colorectal carcinoma cells via oxidative stress

European Journal of Pharmacology

Volumn 637, Issue 1-3, 2010, Pages 55-61

  Li, Haitao ^a   Wu, William Ka Kei ^b   Zheng, Zongping ^a   Che, Chun Tao ^b   Li, Zhi Jie ^b   Xu, Dan Dan ^b   Wong, Clover Ching Man ^b   Ye, Cai Guo ^b   Sung, Joseph Jao Yiu ^b   Cho, Chi Hin ^b   Wang, Mingfu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Colon cancer; Hydroxylated resveratrol derivative; Oxidative stress

Indexed keywords

3,3',4,4',5,5' HEXAHYDROXYSTILBENE; 3,3',4,4,5' PENTAHYDROXYSTILBENE; 3,4,4',5 TETRAHYDROXYSTILBENE; ANTINEOPLASTIC AGENT; CASPASE 8; OXYRESVERATROL; PICEATANNOL; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BCL 2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; RESVERATROL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; CARCINOMA CELL; CELL GROWTH; CELL STRAIN HT29; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY TEST; DNA FRAGMENTATION; DOWN REGULATION; DRUG POTENCY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; NUCLEOSOME; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

EID: 77953288212     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.04.009     Document Type: Article

References (30)

1. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006, 5:493-506.
2. Chen Q., Espey M.G., Sun A.Y., Pooput C., Kirk K.L., Krishna M.C., Khosh D.B., Drisko J., Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc. Natl Acad. Sci. USA 2008, 105:11105-11109.
3. Datta S.R., Ranger A.M., Lin M.Z., Sturgill J.F., Ma Y.C., Cowan C.W., Dikkes P., Korsmeyer S.J., Greenberg M.E. Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. Dev. Cell 2002, 3:631-643.
4. Dolado I., Nebreda A.R. Akt and oxidative stress team up to kill cancer cells. Cancer 2008, 14:427-429.
5. Gu X., Song X., Dong Y., Cai H., Walters E., Zhang R., Peng X., Xie T., Guo Y., Sridhar R., Califano J.A. Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo. Clin. Cancer Res. 2008, 14:1840-1848.
6. Horvath M., Murias M., Saiko P., Erker T., Handler N., Madlener S., Jager W., Fritzer-Szekeres M., Krupitza G. Cytotoxic and biochemical effects of 3, 3', 4, 4', 5, 5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells. Exp. Hematol. 2006, 34:1377-1384.
7. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
8. Kroemer G., Martin S.J. Caspase-independent cell death. Nat. Med. 2005, 11:725-730.
9. Kuwana T., Newmeyer D.D. Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr. Opin. Cell Biol. 2003, 15:691-699.
10. Lastra C.A., Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem. Soc. Trans. 2007, 35:1156-1160.
11. Lee K.W., Kang N.J., Rogozin E.A., Oh S.M., Heo Y.S., Pugliese A., Bode A.M., Lee H.J., Dong Z. The resveratrol analogue 3, 5, 3', 4', 5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEK. Int. J. Cancer 2008, 123:2487-2496.
12. Li H., Cheng K.W., Cho C.H., He Z., Wang M. Oxyresveratrol as an antibrowning agent for cloudy apple. J. Agric. Food Chem. 2007, 55:2604-2610.
13. Lion C.J., Matthews C.S., Stevens M.F.G., Westwell A.D. Synthesis, antitumor evaluation, and apoptosis-inducing activity of hydroxylated (E)-stilbenes. J. Med. Chem. 2005, 48:1292-1295.
14. Lu J., Ho C.T., Ghai G., Chen K.K. Resveratrol analog, 3, 4, 5, 4'-tetrahydroxystilbene, differentially induced pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts. Carcinogenesis 2001, 22:321-328.
15. Murias M., Handler N., Erker T., Pleban K., Ecker G., Saiko P., Szekeres T., Jager W. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg. Med. Chem. 2004, 12:5571-5578.
16. Murias M., Jager W., Handler N., Erker T., Horvath Z., Szekeres T., Nohl H., Gille L. Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochem. Pharmacol. 2005, 69:903-912.
17. Murias M., Luczak M.W., Niepsuj A., Krajka-Kuzniak V., Zielinska-Przyjemska M., Jagodzinski P.P., Jager W., Szekeres T., Jodynis-Liebert J. Cytotoxic activity of 3, 3', 4, 4', 5, 5'-hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase. Toxicol. In Vitro 2008, 22:1361-1370.
18. Nakazato T., Ito K., Miyakawa Y., Kinjo K., Yamada T., Hozumi N., Ikeda Y., Kiza M. Catechin, a green tea component, rapidly induces apoptosis of myeloid leukemic cells via modulation of reactive oxygen species production in vitro and inhibits tumor growth in vivo. Haematologica 2005, 90:317-325.
19. Nogueira V., Park Y., Chen C.C., Xu P.Z., Chen M.L., Tonic I., Unterman T., Hay N. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell. 2008, 14:458-470.
20. Pervaiz S. Chemotherapeutic potential of the chemopreventive phytoalexin resveratrol. Drug Resist Updat. 2004, 6:333-344.
21. Qian Y.P., Cai Y.J., Fan G.J., Wei Q.Y., Yang J., Zheng L.F., Li X.Z., Fang J.G., Zhou B. Antioxidant-based lead discovery for cancer chemoprevention: the case of resveratrol. J. Med. Chem. 2009, 52:1963-1974.
22. Sakagami H., Satoh K., Hakeda Y., Kumegawa M. Apoptosis-inducing activity of vitamin C and vitamin K. Cell. Mol. Biol. 2000, 46:129-143.
23. Sandur S.K., Ichikawa H., Pandey M.K., Kunnumakkara A.B., Sung B., Sethi G., Aggarwal B.B. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic. Biol. Med. 2007, 43:568-580.
24. Scott E.N., Gescher A.J., Steward W.P., Brown K. Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials. Cancer Prev. Res. 2009, 6:525-530.
25. She Q.B., Ma W.Y., Wang M., Kaji A., Ho C.T., Dong Z. Inhibition of cell transformation by resveratrol and its derivatives: differential effects and mechanisms involved. Oncogene 2003, 22:2143-2150.
26. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 2002, 9:459-470.
27. Wang M., Jin Y., Ho C.T. Evaluation of resveratrol derivatives as potential antioxidants and identification of a reaction product of resveratrol and 2, 2-dipphenyl-1-picryhydrazyl radical. J. Agric. Food Chem. 1999, 47:3974-3977.
28. Wen J., You K.R., Lee S.Y., Song C.H., Kim D.G. Oxidative stress-mediated apoptosis. J. Biol. Chem. 2002, 277:38954-38964.
29. Zheng L.F., Wei Q.Y., Cai Y.J., Fang J.G., Zhou B., Yang L., Liu Z.L. DNA damage induced by resveratrol and its synthetic analogues in the presence of Cu(II) ions: mechanism and structure-activity relationship. Free Radic. Biol. Med. 2006, 41:1807-1816.
30. Zykova T.A., Zhu F., Zhai X., Ma W.Y., Ermakova S.P., Lee K.W., Bode A.M., Dong Z. Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol. Carcinogen. 2008, 47:797-805.